GS-9901

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-9901, covering 2015-10-19 to 2015-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma [Phase 1]

See pricing